VYNE Therapeutics Inc (VYNE)
2.42
-0.15
(-5.84%)
USD |
NASDAQ |
Apr 25, 16:00
2.42
0.00 (0.00%)
After-Hours: 20:00
VYNE Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 87.54% |
| September 30, 2020 | 88.65% |
| Date | Value |
|---|---|
| June 30, 2020 | 98.15% |
| March 31, 2020 | 84.51% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
84.51%
Minimum
Mar 2020
98.15%
Maximum
Jun 2020
89.71%
Average
88.10%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Viking Therapeutics Inc | -- |
| AN2 Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -81.22% |
| Return on Assets | -65.28% |
| Return on Invested Capital | -81.22% |
| Profit Margin (Quarterly) | -8.14K% |
| Operating Margin (Quarterly) | -8.99K% |